Literature DB >> 25158895

Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?

Hua Xu1, Meng-Bo Hu, Pei-de Bai, Wen-Hui Zhu, Qiang Ding, Hao-Wen Jiang.   

Abstract

PURPOSE: We aimed to examine the effect of high-fat diet (HFD) on prostate cancer (PCa) development and progression and to investigate whether metformin would postpone PCa development and progression promoted by HFD.
METHODS: TRAMP mice were randomly divided into three groups: normal diet group, HFD group and metformin-HFD (Met-HFD) group. Mortality rate and tumor formation rate were examined. TRAMP mice were sacrificed and sampled on the 20th, 24(th), and 28th week, respectively. Serum levels of insulin and IGF-1 were tested by ELISA. Prostate tissue of TRAMP mice was used for HE staining.
RESULTS: A total of 17 deaths of TRAMP mice were observed, including 3 (10 %) from the normal diet group, 10 (33.33 %) from the HFD group, and 4 (13.33 %) from Met-HFD group. The mortality rate of TRAMP mice from HFD group was significantly higher than that of normal diet group (P = 0.028), and metformin could moderately decrease the mortality rate by 60.01 % (P = 0.067). Tumor formation rates were not significantly different among the three groups. Levels of glucose, insulin, and IGF-1 tended to increase with TRAMP mice's age in HFD group. TRAMP mice from HFD group had higher serum insulin and IGF-1 levels. A moderate decrease in IGF-1 was also seen in Met-HFD group.
CONCLUSIONS: HFD could promote TRAMP mouse PCa development and progression and metformin had moderate effect of reducing PCa mortality rate with a decrease in serum IGF-1 level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25158895     DOI: 10.1007/s11255-014-0823-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  29 in total

1.  Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus.

Authors:  H Yki-Järvinen; K Nikkilä; S Mäkimattila
Journal:  Drugs       Date:  1999       Impact factor: 9.546

2.  Prostate cancer 2000.

Authors:  W F Bodmer
Journal:  Prostate Cancer Prostatic Dis       Date:  2000-12       Impact factor: 5.554

3.  C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome.

Authors:  Catherine Gallou-Kabani; Alexandre Vigé; Marie-Sylvie Gross; Jean-Pierre Rabès; Catherine Boileau; Christiane Larue-Achagiotis; Daniel Tomé; Jean-Philippe Jais; Claudine Junien
Journal:  Obesity (Silver Spring)       Date:  2007-08       Impact factor: 5.002

4.  High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats.

Authors:  Sunil K Panchal; Hemant Poudyal; Abishek Iyer; Reeza Nazer; Ashraful Alam; Vishal Diwan; Kathleen Kauter; Conrad Sernia; Fiona Campbell; Leigh Ward; Glenda Gobe; Andrew Fenning; Lindsay Brown
Journal:  J Cardiovasc Pharmacol       Date:  2011-01       Impact factor: 3.105

5.  Effects of high-fat diet on the patterns of prostatic cancer induced in rats by N-nitrosobis(2-oxopropyl)amine and testosterone.

Authors:  P M Pour; K Groot; K Kazakoff; K Anderson; A V Schally
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

6.  The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

Authors:  I Ben Sahra; K Laurent; A Loubat; S Giorgetti-Peraldi; P Colosetti; P Auberger; J F Tanti; Y Le Marchand-Brustel; F Bost
Journal:  Oncogene       Date:  2008-01-21       Impact factor: 9.867

7.  Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats.

Authors:  K K Carroll; R L Noble
Journal:  Carcinogenesis       Date:  1987-06       Impact factor: 4.944

8.  Metastatic prostate cancer in a transgenic mouse.

Authors:  J R Gingrich; R J Barrios; R A Morton; B F Boyce; F J DeMayo; M J Finegold; R Angelopoulou; J M Rosen; N M Greenberg
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

9.  Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats.

Authors:  M Pollard; P H Luckert
Journal:  Cancer Lett       Date:  1986-08       Impact factor: 8.679

10.  Foods, nutrients and prostate cancer: a case-control study in Uruguay.

Authors:  H Deneo-Pellegrini; E De Stefani; A Ronco; M Mendilaharsu
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more
  7 in total

Review 1.  Lipid metabolism and carcinogenesis, cancer development.

Authors:  Jia Long; Chan-Juan Zhang; Neng Zhu; Ke Du; Yu-Fang Yin; Xi Tan; Duan-Fang Liao; Li Qin
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

Review 2.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

3.  A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice.

Authors:  Jimeng Hu; Tian Yang; Hua Xu; Mengbo Hu; Hui Wen; Haowen Jiang
Journal:  Int Urol Nephrol       Date:  2016-06-09       Impact factor: 2.370

4.  Proinflammatory cytokines in prostate cancer development and progression promoted by high-fat diet.

Authors:  Hua Xu; Meng-bo Hu; Pei-de Bai; Wen-hui Zhu; Sheng-hua Liu; Jun-yao Hou; Zu-quan Xiong; Qiang Ding; Hao-wen Jiang
Journal:  Biomed Res Int       Date:  2015-02-04       Impact factor: 3.411

5.  Lipidomics investigations into the tissue phospholipidomic landscape of invasive ductal carcinoma of the breast.

Authors:  Ravindra Taware; Tushar H More; Muralidhararao Bagadi; Khushman Taunk; Anupama Mane; Srikanth Rapole
Journal:  RSC Adv       Date:  2020-12-22       Impact factor: 3.361

Review 6.  The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review.

Authors:  Chin-Hsiao Tseng
Journal:  World J Mens Health       Date:  2021-03-09       Impact factor: 5.400

7.  Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients.

Authors:  Vita Birzniece; Teresa Lam; Mark McLean; Navneeta Reddy; Haleh Shahidipour; Amy Hayden; Howard Gurney; Glenn Stone; Rikke Hjortebjerg; Jan Frystyk
Journal:  Endocr Connect       Date:  2022-04-29       Impact factor: 3.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.